Yumeng Mao
Universitetslektor vid Institutionen för immunologi, genetik och patologi, Cancerimmunterapi; Forskargrupp Yumeng Mao
- E-post:
- yumeng.mao[AT-tecken]igp.uu.se
- Besöksadress:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postadress:
- Rudbecklaboratoriet
751 85 UPPSALA
Nyckelord: drug discovery cancer immune checkpoint immune resistance crispr-cas9 pd1 pdl1 myeloid cells
Detta stycke finns inte på svenska, därför visas den engelska versionen.
Complete list of publications with citations on google scholar
https://scholar.google.com/citations?user=yx76OvsAAAAJ&hl=en
Detta stycke finns inte på svenska, därför visas den engelska versionen.
Yumeng Mao is a Fellow at the Science for Life Laboratory and an associate senior lecturer at the Department of Immunology, Genetics and Pathology in Uppsala University. The research group aims to overcome resistance mechanisms against the PD-1/PD-L1 blockade therapy in cancer patients by elucidating the negative immune regulatory network using CRISPR/Cas9 precise genome editing (PGE) technology. The group has a special interest on rare cancer types where immunotherapy is less explored, e.g. childhood solid cancers. Prior to the appointment, Yumeng spent a few years at the Oncology R&D headquarter at AstraZeneca in Cambridge, United Kingdom, where he identified and led early drug discovery projects for novel cancer immunotherapy targets. He started his research career in cancer immunology in 2009 with Dr. Karl-Erik Hellström at the University of Washington (USA) and trained as a PhD candidate at the Karolinska Institute (Sweden) under the supervision of Prof. Rolf Kiessling. Yumeng was born and raised in Xi’an, China, where he obtained his undergraduate degree in Life Sciences.
Kontakta katalogansvarig vid den aktuella organisationen (institution eller motsv.) för att rätta ev. felaktigheter.
